全文获取类型
| 收费全文 | 3432366篇 |
| 免费 | 250817篇 |
| 国内免费 | 9213篇 |
专业分类
| 耳鼻咽喉 | 46437篇 |
| 儿科学 | 113225篇 |
| 妇产科学 | 95741篇 |
| 基础医学 | 481785篇 |
| 口腔科学 | 94770篇 |
| 临床医学 | 314647篇 |
| 内科学 | 673752篇 |
| 皮肤病学 | 81392篇 |
| 神经病学 | 282403篇 |
| 特种医学 | 130798篇 |
| 外国民族医学 | 1111篇 |
| 外科学 | 512475篇 |
| 综合类 | 74084篇 |
| 现状与发展 | 7篇 |
| 一般理论 | 1337篇 |
| 预防医学 | 267520篇 |
| 眼科学 | 77710篇 |
| 药学 | 248351篇 |
| 8篇 | |
| 中国医学 | 7252篇 |
| 肿瘤学 | 187591篇 |
出版年
| 2019年 | 27448篇 |
| 2018年 | 38504篇 |
| 2017年 | 29551篇 |
| 2016年 | 33966篇 |
| 2015年 | 38249篇 |
| 2014年 | 53294篇 |
| 2013年 | 80015篇 |
| 2012年 | 106774篇 |
| 2011年 | 113247篇 |
| 2010年 | 67847篇 |
| 2009年 | 64764篇 |
| 2008年 | 105256篇 |
| 2007年 | 111675篇 |
| 2006年 | 113520篇 |
| 2005年 | 109229篇 |
| 2004年 | 104751篇 |
| 2003年 | 101007篇 |
| 2002年 | 97599篇 |
| 2001年 | 165399篇 |
| 2000年 | 169461篇 |
| 1999年 | 142494篇 |
| 1998年 | 41213篇 |
| 1997年 | 36694篇 |
| 1996年 | 36717篇 |
| 1995年 | 35511篇 |
| 1994年 | 32421篇 |
| 1993年 | 30340篇 |
| 1992年 | 110011篇 |
| 1991年 | 105611篇 |
| 1990年 | 102327篇 |
| 1989年 | 98573篇 |
| 1988年 | 90426篇 |
| 1987年 | 88588篇 |
| 1986年 | 82968篇 |
| 1985年 | 79402篇 |
| 1984年 | 59542篇 |
| 1983年 | 50466篇 |
| 1982年 | 30176篇 |
| 1981年 | 26904篇 |
| 1979年 | 52629篇 |
| 1978年 | 37249篇 |
| 1977年 | 31390篇 |
| 1976年 | 29244篇 |
| 1975年 | 30830篇 |
| 1974年 | 36712篇 |
| 1973年 | 35096篇 |
| 1972年 | 32985篇 |
| 1971年 | 30512篇 |
| 1970年 | 28348篇 |
| 1969年 | 26991篇 |
排序方式： 共有10000条查询结果，搜索用时 10 毫秒
21.
22.
23.
24.
25.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献26.
27.
Ludger Klimek Annette Sperl Sven Becker Ralph Mösges Peter Valentin Tomazic 《Expert opinion on pharmacotherapy》2019,20(1):83-89
Introduction: Allergic rhinitis is a common condition with increasing prevalence and is associated with several comorbid disorders such as bronchial asthma and atopic dermatitis. If allergen avoidance is not possible, allergen-specific immunotherapy is the only causal treatment option.
Areas covered: This review focuses on current treatments and the future outlook for allergic rhinitis. Pharmacotherapy includes mast cell stabilizers, antihistamines, glucocorticosteroids (GCSs), leukotriene receptor antagonists, and nasal decongestants. Nasal GCSs are currently regarded as the most effective treatment and are considered first-line therapy together with non-sedating antihistamines. The new formulation MP29-02 combines the nasal GCS fluticasone propionate with azelastine in one single spray and has achieved greater improvements than those under monotherapy with modern GCSs or antihistamines. Furthermore, this review discusses allergen immunotherapy alone and in combination with modern monoclonal antibodies.
Expert opinion: Despite the variety of medications for allergic rhinitis, ranging from general symptomatic agents like GCSs or decongestants, to more specific ones like histamine receptor or leukotriene blockers, to causal therapy like immunotherapy, many patients still experience treatment failures or unsatisfactory results. The ultimate goal may be to endotype every downstream pathway separately in order to offer patients individualized, targeted therapy with specific antibodies against the respective pathway. 相似文献
28.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献29.
30.